Hims & Hers Health HIMS
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 39th percentile, 5-year average -101.3x
Above its usual level · 67th percentile, 5-year average 10.3x
#5039 of 5331 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 5th percentile, 5-year average 3.5x
#2252 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 13.01 | – | 10.27 | 67% (pricier than usual) | #5039 of 5331 (1 = cheapest) |
| PE | -23.77 | -61.10 | -101.25 | 39% (cheaper than usual) | – |
| PS | 1.61 | 1.25 | 3.52 | 5% (cheaper than usual) | #2252 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on HIMS.
Sign in to join the discussion.